Intuitive Surgical, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Intuitive Surgical, Inc. (ISRG) reported Foreign Currency Transaction Gain (Loss), before Tax of -$4.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-07-21
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$4.70M, a 125.00% decline year-over-year.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$19.20M, a 349.35% decline year-over-year.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$19.70M.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$14.30M, a 145.40% decline year-over-year.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$7.50M.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$45.90M.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$8.50M.
- Intuitive Surgical, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$54.20M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.70M 10-Q · filed 2026-07-21 | -$23.90M 10-Q · filed 2026-07-21 | -$43.60M derived: sum of 3 quarters · filed 2026-07-21 | -$57.90M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2026-03-31 | -$19.20M 10-Q · filed 2026-04-22 | -$38.90M derived: sum of 2 quarters · filed 2026-04-22 | -$53.20M derived: sum of 3 quarters · filed 2026-04-22 | -$34.40M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-12-31 | -$19.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | -$34.00M derived: sum of 2 quarters · filed 2026-02-03 | -$15.20M derived: sum of 3 quarters · filed 2026-07-21 | -$7.50M 10-K · filed 2026-02-03 | ||||
| 2025-09-30 | -$14.30M 10-Q · filed 2025-10-22 | $4.50M derived: sum of 2 quarters · filed 2026-07-21 | $12.20M 10-Q · filed 2025-10-22 | -$32.60M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-06-30 | $18.80M 10-Q · filed 2026-07-21 | $26.50M 10-Q · filed 2026-07-21 | -$18.30M derived: sum of 3 quarters · filed 2026-07-21 | $13.20M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-03-31 | $7.70M 10-Q · filed 2026-04-22 | -$37.10M derived: sum of 2 quarters · filed 2026-04-22 | -$5.60M derived: sum of 3 quarters · filed 2026-04-22 | -$18.80M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-31 | -$44.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | -$13.30M derived: sum of 2 quarters · filed 2026-02-03 | -$26.50M derived: sum of 3 quarters · filed 2026-02-03 | -$45.90M 10-K · filed 2026-02-03 | ||||
| 2024-09-30 | $31.50M 10-Q · filed 2025-10-22 | $18.30M derived: sum of 2 quarters · filed 2025-10-22 | -$1.10M 10-Q · filed 2025-10-22 | $14.40M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-06-30 | -$13.20M 10-Q · filed 2025-07-23 | -$32.60M 10-Q · filed 2025-07-23 | -$17.10M derived: sum of 3 quarters · filed 2026-02-03 | -$30.20M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-03-31 | -$19.40M 10-Q · filed 2025-04-23 | -$3.90M derived: sum of 2 quarters · filed 2026-02-03 | -$17.00M derived: sum of 3 quarters · filed 2026-02-03 | -$33.30M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2023-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $2.40M derived: sum of 2 quarters · filed 2026-02-03 | -$13.90M derived: sum of 3 quarters · filed 2026-02-03 | -$8.50M 10-K · filed 2026-02-03 | ||||
| 2023-09-30 | -$13.10M 10-Q · filed 2024-10-18 | -$29.40M derived: sum of 2 quarters · filed 2024-10-18 | -$24.00M 10-Q · filed 2024-10-18 | -$8.80M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-06-30 | -$16.30M 10-Q · filed 2024-07-19 | -$10.90M 10-Q · filed 2024-07-19 | $4.30M derived: sum of 3 quarters · filed 2025-01-31 | -$26.20M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-03-31 | $5.40M 10-Q · filed 2024-04-19 | $20.60M derived: sum of 2 quarters · filed 2025-01-31 | -$9.90M derived: sum of 3 quarters · filed 2025-01-31 | -$38.70M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2022-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | -$15.30M derived: sum of 2 quarters · filed 2025-01-31 | -$44.10M derived: sum of 3 quarters · filed 2025-01-31 | -$54.20M 10-K · filed 2025-01-31 | ||||
| 2022-09-30 | -$30.50M 10-Q · filed 2023-10-20 | -$59.30M derived: sum of 2 quarters · filed 2023-10-20 | -$69.40M 10-Q · filed 2023-10-20 | -$73.40M derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2022-06-30 | -$28.80M 10-Q · filed 2023-07-24 | -$38.90M 10-Q · filed 2023-07-24 | -$42.90M derived: sum of 3 quarters · filed 2024-01-31 | -$49.30M derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2022-03-31 | -$10.10M 10-Q · filed 2023-04-20 | -$14.10M derived: sum of 2 quarters · filed 2024-01-31 | -$20.50M derived: sum of 3 quarters · filed 2024-01-31 | -$15.50M derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2021-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | -$10.40M derived: sum of 2 quarters · filed 2024-01-31 | -$5.40M derived: sum of 3 quarters · filed 2024-01-31 | -$16.40M 10-K · filed 2024-01-31 | ||||
| 2021-09-30 | -$6.40M 10-Q · filed 2022-10-21 | -$1.40M derived: sum of 2 quarters · filed 2022-10-21 | -$12.40M 10-Q · filed 2022-10-21 | $3.50M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-06-30 | $5.00M 10-Q · filed 2022-07-22 | -$6.00M 10-Q · filed 2022-07-22 | $9.90M derived: sum of 3 quarters · filed 2023-02-10 | $15.80M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-03-31 | -$7.10M 10-Q · filed 2022-04-22 | $4.90M derived: sum of 2 quarters · filed 2023-02-10 | $10.80M derived: sum of 3 quarters · filed 2023-02-10 | $12.50M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2020-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $17.90M derived: sum of 2 quarters · filed 2023-02-10 | $19.60M derived: sum of 3 quarters · filed 2023-02-10 | $10.90M 10-K · filed 2023-02-10 | ||||
| 2020-09-30 | $5.90M 10-Q · filed 2021-10-20 | $7.60M derived: sum of 2 quarters · filed 2021-10-20 | -$1.10M 10-Q · filed 2021-10-20 | $1.00M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $1.70M 10-Q · filed 2021-07-21 | -$6.90M 10-Q · filed 2021-07-21 | -$4.90M derived: sum of 3 quarters · filed 2022-02-03 | -$8.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$8.60M 10-Q · filed 2021-04-21 | -$6.60M derived: sum of 2 quarters · filed 2022-02-03 | -$10.40M derived: sum of 3 quarters · filed 2022-02-03 | -$8.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$1.80M derived: sum of 2 quarters · filed 2022-02-03 | $300.00K derived: sum of 3 quarters · filed 2022-02-03 | -$1.50M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | -$3.80M 10-Q · filed 2020-10-19 | -$1.70M derived: sum of 2 quarters · filed 2020-10-19 | -$3.50M 10-Q · filed 2020-10-19 | |||||
| 2019-06-30 | $2.10M 10-Q · filed 2020-07-23 | $300.00K 10-Q · filed 2020-07-23 | ||||||
| 2019-03-31 | -$1.80M 10-Q · filed 2020-04-17 | |||||||
| 2018-12-31 | -$2.60M 10-K · filed 2021-02-10 | |||||||
| 2017-12-31 | $9.70M 10-K · filed 2020-02-07 | |||||||
| 2016-12-31 | -$5.60M 10-K · filed 2019-02-04 | |||||||
| 2015-12-31 | -$7.90M 10-K · filed 2018-02-02 | |||||||
| 2014-12-31 | -$6.90M 10-K · filed 2017-02-06 | |||||||
| 2014-03-31 | -$600.00K 10-Q · filed 2014-04-25 | $1.50M derived: sum of 2 quarters · filed 2016-02-02 | $3.90M derived: sum of 3 quarters · filed 2016-02-02 | $4.00M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2013-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $4.50M derived: sum of 2 quarters · filed 2016-02-02 | $4.60M derived: sum of 3 quarters · filed 2016-02-02 | $3.10M 10-K · filed 2016-02-02 | ||||
| 2013-09-30 | $2.40M 10-Q · filed 2013-10-18 | $2.50M derived: sum of 2 quarters · filed 2013-10-18 | $1.00M 10-Q · filed 2013-10-18 | $2.20M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-22 | -$1.30M 10-Q · filed 2013-07-22 | -$200.00K derived: sum of 3 quarters · filed 2015-02-06 | $0.00 derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-03-31 | -$1.40M 10-Q · filed 2014-04-25 | -$300.00K derived: sum of 2 quarters · filed 2015-02-06 | -$100.00K derived: sum of 3 quarters · filed 2015-02-06 | -$1.20M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2012-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $1.30M derived: sum of 2 quarters · filed 2015-02-06 | $200.00K derived: sum of 3 quarters · filed 2015-02-06 | $700.00K 10-K · filed 2015-02-06 | $300.00K 10-K · filed 2013-02-04 | |||
| 2012-09-30 | $200.00K 10-Q · filed 2013-10-18 | $0.00 10-Q · filed 2012-10-18 | -$900.00K derived: sum of 2 quarters · filed 2013-10-18 | -$400.00K 10-Q · filed 2013-10-18 | -$600.00K 10-Q · filed 2012-10-18 | -$1.60M derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2012-06-30 | -$1.10M 10-Q · filed 2013-07-22 | -$600.00K 10-Q · filed 2013-07-22 | -$1.80M derived: sum of 3 quarters · filed 2014-02-03 | -$3.50M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-03-31 | $500.00K 10-Q · filed 2013-04-19 | -$700.00K derived: sum of 2 quarters · filed 2014-02-03 | -$2.40M derived: sum of 3 quarters · filed 2014-02-03 | -$1.40M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2011-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | -$2.90M derived: sum of 2 quarters · filed 2014-02-03 | -$1.90M derived: sum of 3 quarters · filed 2014-02-03 | $300.00K 10-K · filed 2014-02-03 | ||||
| 2011-09-30 | -$1.70M 10-Q · filed 2012-10-18 | -$700.00K derived: sum of 2 quarters · filed 2012-10-18 | $1.50M 10-Q · filed 2012-10-18 | $900.00K derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-06-30 | $1.00M 10-Q · filed 2012-07-23 | $3.30M 10-Q · filed 2012-07-23 | $2.60M derived: sum of 3 quarters · filed 2013-02-04 | $5.50M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-03-31 | $2.30M 10-Q · filed 2012-04-19 | $1.60M derived: sum of 2 quarters · filed 2013-02-04 | $4.50M derived: sum of 3 quarters · filed 2013-02-04 | $2.30M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2010-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $2.20M derived: sum of 2 quarters · filed 2013-02-04 | $0.00 derived: sum of 3 quarters · filed 2013-02-04 | -$2.60M 10-K · filed 2013-02-04 | ||||
| 2010-09-30 | $2.90M 10-Q · filed 2011-10-19 | $700.00K derived: sum of 2 quarters · filed 2011-10-19 | -$1.90M 10-Q · filed 2011-10-19 | |||||
| 2010-06-30 | -$2.20M 10-Q · filed 2011-07-20 | $2.20M 10-Q · filed 2010-07-23 | -$4.90M 10-Q · filed 2011-07-20 | $4.90M 10-Q · filed 2010-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |